Home
About
Publications Trends
Recent Publications
Expert Search
Archive
decitabine
What Are the Side Effects of Decitabine?
Like most chemotherapeutic agents, decitabine comes with a range of potential
side effects
. Common side effects include:
Nausea and vomiting
Fatigue
Fever
Low blood cell counts (anemia, neutropenia, thrombocytopenia)
Infection
More severe side effects can include bleeding, severe infections, and liver toxicity. Regular monitoring by healthcare providers is essential to manage these risks effectively.
Frequently asked queries:
What is Decitabine?
How Does Decitabine Work?
What Types of Cancer is Decitabine Used For?
What Are the Side Effects of Decitabine?
How is Decitabine Administered?
What are the Benefits of Decitabine?
Are There Any Limitations or Risks?
What Types of Data Are Used in Retrospective Analyses?
What Are the Psychological Benefits of Holistic Medicine for Cancer Patients?
How Does NIST Ensure the Quality of Cancer Diagnostics?
Who Can Benefit from Ovarian Tissue Freezing?
How is Dynein Associated with Cancer?
When Should Cancer Patients Wash Their Hands?
What Happens During a Hysteroscopy Procedure?
What Types of Cancer Commonly Cause Jaundice?
Does Early Detection Reduce the Impact of Chance?
What are the Sources of VOC Exposure?
What is Life Saving Equipment in Cancer Treatment?
When Should a Cancer Patient Seek Medical Attention for Headaches?
How is Non-Hodgkin's Lymphoma Diagnosed?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe